DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
Effective January 14, 2018, DENTSPLY SIRONA Inc. (the “Company”) appointed Betsy D. Holden and Leslie F. Varon to the Board of Directors of the Company (the “Board”) and expanded the size of the Board from nine members to 11 members. Ms. Holden will serve as a member of the Board’s Human Resources Committee, and Ms. Varon will serve as a member of its Audit and Finance Committee. Ms. Holden and Ms. Varon will participate in the same compensation plans as the other non-employee members of the Board, as presently described under “2016 Compensation of Directors” in the Company’s proxy statement dated April 13, 2017 for its 2017 annual meeting of stockholders. The Board’s Chairman, Eric K. Brandt, ceased his service on those committees effective as of the appointment of Ms. Holden and Ms. Varon. As is being separately disclosed today, Donald M. Casey Jr. will also join the Board upon his appointment as Chief Executive Officer of the Company effective February 12, 2018, at which time the size of the Board will increase from 11 members to 12 members.
Item 8.01 Other Events.
On January 17, 2018, the Company issued a press release announcing the appointment of Ms. Holden and Ms. Varon. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
DENTSPLY SIRONA Inc. ExhibitEX-99.1 2 ex99-1.htm EXHIBIT 99.1 – PRESS RELEASE Exhibit 99.1 Dentsply Sirona Announces the Addition of New Board Members York,…To view the full exhibit click here
About DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
DENTSPLY SIRONA Inc., formerly DENTSPLY International Inc., designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products. The Company’s segments include Dental Consumables, Endodontic and Dental Laboratory Businesses; Healthcare, Orthodontic and Implant Businesses, and Select Developed and Emerging Markets Businesses. The Company’s principal product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Company distributes its products in over 120 countries. It offers brands, such as ANKYLOS, AQUASIL ULTRA, ARTICADENT, XIVE, ORAQIX, XYLOCAINE, ZHERMACK, IN-OVATION, LOFRIC, MAILLEFER, MIDWEST, NUPRO, ORIGO, OSSEOSPEED and PALODENT PLUS.
